Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
SANOFICONR
₹4,224.10
₹4182.00
₹4281.00
₹3975.00
₹5357.00
Markets Today
Historical Performance
As of 24-08-2026 13:27, Sanofi Consumer Healthcare India Ltd. share price today is ₹0, with a change of ₹-4222.10 (-100.00%) from the previous close of ₹4222.1. The stock opened at ₹4202 and traded between ₹4182 and ₹4281, with a total traded volume of 2050 shares. The company has a market capitalization of ₹9722.8 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹5357 and ₹3975, respectively.
Sanofi Consumer Healthcare India Ltd. valuation metrics include a P/E ratio of 36.6, and book value of ₹25.30. Profitability indicators show ROE of 62.52% along with a dividend yield of 1.8%. Sanofi Consumer Healthcare India Ltd. has reported revenue of ₹949.8 Cr and net profit of ₹266 Cr.
Sanofi Consumer Healthcare India Ltd. technical indicators include Day RSI at 23.87, Day MFI at 10.84, Day ADX at 20.64. Additional indicators include Commodity Channel Index (CCI) at -203.4 and Williams %R at -97.64. Momentum indicators show Day MACD at -74.79, Day MACD Signal Line at -44.09, DayATR at 103.48. Rate of Change indicators for Sanofi Consumer Healthcare India Ltd. include ROC125 at -1.6 and ROC21 at -7.76.
Exponential moving averages include EMA5 at ₹4345.8, EMA10 at ₹4416.8, EMA12 at ₹4435.8, EMA20 at ₹4486.4, EMA26 at ₹4510.6, EMA50 at ₹4558.1, EMA100 at ₹4572.4, EMA200 at ₹4602.4. Simple moving averages include SMA5 at ₹4367.6, SMA10 at ₹4442.3, SMA20 at ₹4536.9, SMA30 at ₹4544.3, SMA50 at ₹4595.1, SMA100 at ₹4617.2, SMA150 at ₹4487.6, SMA200 at ₹4525.2.
Support levels for Sanofi Consumer Healthcare are placed at First Support ₹4173.27, Second Support ₹4124.83, Third Support ₹4038.57. Resistance levels are seen at First Resistance ₹4307.97, Second Resistance ₹4394.23, Third Resistance ₹4442.67. Sanofi Consumer Healthcare India Ltd. shareholding pattern shows promoter holding at 71.27%, FII holding at 2.6%, DII holding at 0%, public holding at 8.28%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 235.70 | 229.20 | 251 | 233.90 | 220.90 |
| Operating Expense | 146.40 | 140.40 | 161.20 | 148.90 | 150.70 |
| Operating Profit | 89.30 | 88.80 | 89.80 | 85 | 70.20 |
| Depreciation | 3.30 | 3.20 | 3.40 | 3.30 | 3 |
| Interest | 0.40 | 0.50 | 0.50 | 0.60 | 0.50 |
| Tax | 23.10 | 22.90 | 24 | 21.20 | 18.20 |
| Net Profit | 68.80 | 67.80 | 66.50 | 62.90 | 60.70 |
₹4224.10
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 60.4 | 71.3 | 71.3 | 71.3 | 71.3 | 71.3 |
| FII | 4.5 | 3.2 | 2.9 | 2.8 | 2.8 | 2.6 |
| DII | 25.5 | 16.9 | 17.3 | 17.4 | 17.5 | 17.8 |
| Public | 9.6 | 8.6 | 8.6 | 8.6 | 8.4 | 8.3 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 3.6 K | 5.55 K | 64.98% |
| Week | 4.6 K | 6.13 K | 75.12% |
| 1 Month | 9.66 K | 12.48 K | 77.34% |
| 6 Month | 10.11 K | 25.7 K | 39.36% |
Companies with no Debt
Benjamin Graham Value Screen
Mid-range Performer (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 4 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Volume Shockers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Jun, 2026 | 75 | FINAL | 19 Jun, 2026 | Equity Share |
| 17 Apr, 2025 | 55 | FINAL | 17 Apr, 2025 | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹2,142.40 | ₹1,112 | ₹1,567.40 | ₹1,521.20 | ₹769.50 |
| % Change | -0.01% | 0.02% | 3.57% | -0.90% | 2.60% |
| Revenue TTM (₹ Cr) | ₹1,479.07 | ₹675.61 | ₹691.72 | ₹1,543.34 | ₹4,501.61 |
| Net Profit TTM (₹ Cr) | ₹199.03 | ₹182.64 | ₹126.37 | ₹-48.62 | ₹291.72 |
| PE TTM | 65.20 | 71.50 | 56.50 | -358.60 | 40.60 |
| 1 Year Return | 99.76 | 95.01 | 121.72 | -17.12 | 57.13 |
| ROCE | 31.54 | 24.22 | 15.60 | 0.59 | 11.40 |
Innova Captab Ltd.
₹ 1064.90
-2.17%
Blue Jet Healthcare Ltd
₹ 592.40
-0.63%
Concord Biotech Ltd.
₹ 1542.00
-1.86%
Aarti Pharmalabs Ltd.
₹ 834.50
+2.17%
Supriya Lifescience Ltd.
₹ 802.75
-0.34%
Alivus Life Sciences Ltd.
₹ 1357.00
+0.45%
Cohance Lifesciences Ltd.
₹ 451.25
-2.54%
Eris Lifesciences Ltd.
₹ 1325.00
-0.24%
Syngene International Ltd.
₹ 401.15
-1.50%
Alembic Pharmaceuticals Ltd.
₹ 817.10
-0.57%
Sun Pharma Advanced Research Company Ltd.
₹ 195.80
-0.46%
Strides Pharma Science Ltd.
₹ 982.20
-0.41%
FDC Ltd.
₹ 346.40
-0.63%
Shilpa Medicare Ltd.
₹ 851.60
+4.50%
Jubilant Pharmova Ltd.
₹ 894.00
+1.55%
Natco Pharma Ltd.
₹ 885.00
+0.29%
Caplin Point Laboratories Ltd.
₹ 2502.10
-2.29%
Marksans Pharma Ltd.
₹ 319.30
-0.62%
Orchid Pharma Ltd.
₹ 1031.65
+2.95%
Viyash Scientific Ltd.
₹ 268.45
-2.72%
AstraZeneca Pharma India Ltd.
₹ 7219.00
-2.65%
Bliss GVS Pharma Ltd.
₹ 571.40
-1.33%
Sanofi India Ltd.
₹ 3288.00
-1.93%
Morepen Laboratories Ltd.
₹ 96.51
+0.52%
Procter & Gamble Health Ltd.
₹ 5858.50
+0.51%
By signing up I certify terms, conditions & privacy policy